Patients who have experienced sudden vision loss caused by non-arteritic anterior ischemic optic neuropathy (NAION) after taking Ozempic or other GLP-1 medications often have many questions. Understanding how NAION develops and how it may be connected to medications like Ozempic can help patients make informed decisions about their health and their legal options.
If you took Ozempic, Wegovy, Mounjaro, or another GLP-1 medication and were diagnosed with NAION or sudden vision loss, you may qualify to file a lawsuit.
The law firm of Hissey Mulderig & Friend is investigating claims involving GLP-1 drugs and serious vision injuries. Call 1-866-806-8117 or fill out our free and confidential case evaluation form on the right side of this page to see if you qualify.
➢ What is NAION?
Non-arteritic anterior ischemic optic neuropathy, commonly referred to as NAION, is a condition that occurs when blood flow to the optic nerve becomes reduced or blocked. The optic nerve carries visual signals from the eye to the brain. When the nerve does not receive enough blood supply, the nerve tissue can become damaged, leading to partial or complete vision loss.
Doctors sometimes describe NAION as an “eye stroke” because it involves a sudden interruption of circulation to the optic nerve. Unlike some eye conditions that develop slowly over time, NAION often occurs unexpectedly and may cause permanent damage to vision.
Many people who develop NAION notice vision problems immediately upon waking in the morning. In many cases, the vision loss affects only one eye, although the condition can eventually involve both eyes in some patients.
➢ What are the symptoms of NAION?
NAION typically causes sudden vision loss in one eye, although the severity of vision loss can vary from person to person. Some patients experience mild visual disturbances at first, while others experience significant loss of vision.
Common symptoms of NAION may include:
- Sudden vision loss in one eye
- Blurred or dim vision
- Dark or missing areas in the field of vision
- Reduced color perception
- Vision changes that appear suddenly upon waking
Because NAION affects the optic nerve, the condition often develops without pain. However, the visual impairment can be severe and may become permanent if the optic nerve is significantly damaged.
Anyone experiencing sudden changes in vision should seek medical attention immediately so that doctors can determine the cause and begin appropriate evaluation.
➢ Can Ozempic cause NAION?
Scientists are currently examining whether Ozempic and other GLP-1 receptor agonist medications may increase the risk of non-arteritic anterior ischemic optic neuropathy.
Ozempic contains semaglutide, a medication that affects blood sugar regulation and metabolism. While these drugs are widely used to treat diabetes and support weight loss, scientists have begun examining whether their effects on circulation or vascular health could influence blood flow to the optic nerve.
Some research has suggested that patients taking semaglutide-based medications may have a higher risk of developing NAION compared with individuals using other diabetes treatments. However, researchers continue to evaluate these findings to determine whether a direct causal relationship exists.
As additional studies are conducted, physicians and researchers are working to better understand whether GLP-1 medications may contribute to optic nerve injuries in certain patients.
➢ Which GLP-1 drugs are linked to NAION lawsuits?
Several GLP-1 receptor agonist medications have been linked to an increased risk of NAION in lawsuits filed by patients who developed serious vision problems.
These drugs include:
- Ozempic (semaglutide)
- Wegovy (semaglutide)
- Mounjaro (tirzepatide)
- Rybelsus (semaglutide)
- Saxenda (liraglutide)
- Trulicity (dulaglutide)
These medications are commonly prescribed to treat type 2 diabetes and, in some cases, obesity. Because millions of patients have used these drugs, reports of serious side effects have received increased attention from researchers and regulators.
Patients who filed lawsuits allege that the manufacturers of GLP-1 medications failed to adequately warn about the risk of optic nerve injuries that could lead to permanent vision loss.
➢ How common is NAION among Ozempic users?
NAION is considered a relatively rare eye condition. However, it is one of the most common causes of sudden optic nerve-related vision loss in adults.
Researchers are continuing to study how frequently NAION occurs among patients taking GLP-1 medications such as Ozempic or Wegovy. Some studies have examined whether the rate of NAION may be higher among patients using semaglutide compared with those using other diabetes medications.
Because millions of patients use GLP-1 drugs, even a small increase in risk could affect a significant number of individuals. Additional research is needed to determine how often these medications may be associated with optic nerve injuries.
➢ Can vision loss return after NAION?
Unfortunately, vision loss caused by NAION is often permanent. When the optic nerve becomes damaged due to reduced blood supply, the nerve tissue may not recover.
Some patients experience partial improvement in vision over time, but many individuals continue to have lasting visual impairment. The degree of recovery can vary depending on the severity of the initial injury and the amount of optic nerve damage.
Because of the potential for permanent vision loss, early medical evaluation and ongoing monitoring by an eye specialist are important for anyone diagnosed with NAION.
➢ What should you do if you experience vision loss after Ozempic?
Anyone who experiences sudden vision loss or major visual changes should seek immediate medical attention. An ophthalmologist or neuro-ophthalmologist can evaluate the optic nerve and determine whether NAION or another condition may be responsible for the symptoms.
Patients should also keep records of the medications they have taken, including Ozempic or other GLP-1 drugs. Medical documentation and prescription history may be important for understanding the cause of the injury and evaluating potential legal claims.
If you took Ozempic, Wegovy, Mounjaro, or another GLP-1 medication and were later diagnosed with NAION or sudden vision loss, you may qualify to file a lawsuit.
Contact the law firm of Hissey Mulderig & Friend to discuss your legal options by calling toll-free at 1-866-806-8117, or fill out our free and confidential case evaluation form at the top of this page to see if you qualify.
